FDA Seeks Approval for Generic Drug User Fee Paperwork Updates
Published Date: 5/5/2025
Notice
Summary
The FDA is asking for approval to collect info from companies that make generic drugs. This helps keep the Generic Drug User Fee Program running smoothly, making sure safe and affordable medicines reach you faster. If you’re a drug maker, get ready for some paperwork updates soon!
Analyzed Economic Effects
2 provisions identified: 1 benefits, 1 costs, 0 mixed.
Generic Drug Makers: New Paperwork
The FDA is asking OMB to approve collecting information from companies that make generic drugs. If you make generic medicines, expect paperwork updates and information requests to support the Generic Drug User Fee Program.
Keeps Generics Reaching Patients Faster
The FDA says the information collection helps keep the Generic Drug User Fee Program running smoothly so safe, affordable generic medicines reach patients faster. That could help consumers obtain generic medicines more quickly.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in